BDBM636323 US20230365546, Compound 106

SMILES CC(C)C(=O)Nc1nc2cc(ccn2n1)-c1ccc2n(C)cc(C(=O)N[C@@H](C)c3cccc(F)c3)c2c1

InChI Key InChIKey=WPOMDFBNOALBRN-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 636323   

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Origiant Pharmaceutical

US Patent
LigandPNGBDBM636323(US20230365546, Compound 106)
Affinity DataIC50: 5.5nMAssay Description:In vitro kinase assays were conducted using Kinase Profiler services provided by Eurofins. The experimental method was as follows: the small molecule...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2024
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 1(Human)
Origiant Pharmaceutical

US Patent
LigandPNGBDBM636323(US20230365546, Compound 106)
Affinity DataIC50: 16nMAssay Description:Inhibition of human RIPK1 (1 to 294 residues) preincubated for 15 mins followed by [gamma-33P]ATP addition and measured after 40 mins by scintillatio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed